Resultats de la cerca - Liimatta, Marya
- Mostrar 1 - 7 resultats de 7
-
1
Structure-guided inhibitor design for human FAAH by interspecies active site conversion per Mileni, Mauro, Johnson, Douglas S., Wang, Zhigang, Everdeen, Daniel S., Liimatta, Marya, Pabst, Brandon, Bhattacharya, Keshab, Nugent, Richard A., Kamtekar, Satwik, Cravatt, Benjamin F., Ahn, Kay, Stevens, Raymond C.
Publicat 2008Text -
2
Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH) per Johnson, Douglas S., Ahn, Kay, Kesten, Suzanne, Lazerwith, Scott E., Song, Yuntao, Morris, Mark, Fay, Lorraine, Gregory, Tracy, Stiff, Cory, Dunbar, James B., Liimatta, Marya, Beidler, David, Smith, Sarah, Nomanbhoy, Tyzoon K., Cravatt, Benjamin F.
Publicat 2009Text -
3
Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action per René, Olivier, Fauber, Benjamin P., Boenig, Gladys de Leon, Burton, Brenda, Eidenschenk, Céline, Everett, Christine, Gobbi, Alberto, Hymowitz, Sarah G., Johnson, Adam R., Kiefer, James R., Liimatta, Marya, Lockey, Peter, Norman, Maxine, Ouyang, Wenjun, Wallweber, Heidi A., Wong, Harvey
Publicat 2014Text -
4
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor per Johnson, Douglas S., Stiff, Cory, Lazerwith, Scott E., Kesten, Suzanne R., Fay, Lorraine K., Morris, Mark, Beidler, David, Liimatta, Marya B., Smith, Sarah E., Dudley, David T., Sadagopan, Nalini, Bhattachar, Shobha N., Kesten, Stephen J., Nomanbhoy, Tyzoon K., Cravatt, Benjamin F., Ahn, Kay
Publicat 2010Text -
5
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain per Ahn, Kay, Johnson, Douglas S., Mileni, Mauro, Beidler, David, Long, Jonathan Z., McKinney, Michele K., Weerapana, Eranthie, Sadagopan, Nalini, Liimatta, Marya, Smith, Sarah E., Lazerwith, Scott, Stiff, Cory, Kamtekar, Satwik, Bhattacharya, Keshab, Zhang, Yanhua, Swaney, Stephen, Van Becelaere, Keri, Stevens, Raymond C., Cravatt, Benjamin F.
Publicat 2009Text -
6
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pa... per Ahn, Kay, Smith, Sarah E., Liimatta, Marya B., Beidler, David, Sadagopan, Nalini, Dudley, David T., Young, Tim, Wren, Paul, Zhang, Yanhua, Swaney, Steven, Van Becelaere, Keri, Blankman, Jacqueline L., Nomura, Daniel K., Bhattachar, Shobha N., Stiff, Cory, Nomanbhoy, Tyzoon K., Weerapana, Eranthie, Johnson, Douglas S., Cravatt, Benjamin F.
Publicat 2011Text -
7
Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell–associated damage in IFNα-driven lupus nephritis per Katewa, Arna, Wang, Yugang, Hackney, Jason A., Huang, Tao, Suto, Eric, Ramamoorthi, Nandhini, Austin, Cary D., Bremer, Meire, Chen, Jacob Zhi, Crawford, James J., Currie, Kevin S., Blomgren, Peter, DeVoss, Jason, DiPaolo, Julie A., Hau, Jonathan, Johnson, Adam, Lesch, Justin, DeForge, Laura E., Lin, Zhonghua, Liimatta, Marya, Lubach, Joseph W., McVay, Sami, Modrusan, Zora, Nguyen, Allen, Poon, Chungkee, Wang, Jianyong, Liu, Lichuan, Lee, Wyne P., Wong, Harvey, Young, Wendy B., Townsend, Michael J., Reif, Karin
Publicat 2017Text